Toggle navigation
Home
Search
Services
Blog
Contact
About
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A.
Weill Medical College of Cornell University, New York, NY, United States
Search 7 grants from Michelle Lane
Search grants from Weill Medical College of Cornell University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Renal Endothelin-1: Control of Sodium Excretion and Blood Pressure
General Clinical Research Center
Comparison of Human Insulin Analogue X14 in Type I Diabetes
The Role of Receptors in Vitamin D Hormone Action
Support Services for the Clinical Center
Recently added grants:
The effect of laminar and disturbed flow on endothelial glucose metabolism
Attenuation of atherosclerosis by regulation of VSMC inflammatory gene mRNA stability
Asthma Exacerbations and MicroRNA prediction: Treatment Response in an Underserved Ethnicity (AEM-TRUE)
The complex genetics of heart regeneration
The University of California - Los Angeles (UCLA) Resident Scientist Training Program (RSTP)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA075722-01A1
Application #
2638266
Study Section
Special Emphasis Panel (ZRG2-SSS-1 (01))
Program Officer
Lohrey, Nancy
Project Start
1999-01-22
Project End
Budget Start
1998-08-10
Budget End
1999-08-09
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Weill Medical College of Cornell University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Related projects
NIH 2000
F32 CA
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A. / Weill Medical College of Cornell University
$40,013
NIH 1999
F32 CA
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A. / Weill Medical College of Cornell University
NIH 1998
F32 CA
4-Oxoretinol - Potential New Cancer Therapeutic Drug
Lane, Michelle A. / Weill Medical College of Cornell University
Publications
Lane, Michelle A; Xu, Juliana; Wilen, Elana W et al.
(2008)
LIF removal increases CRABPI and CRABPII transcripts in embryonic stem cells cultured in retinol or 4-oxoretinol.
Mol Cell Endocrinol 280:63-74
Comments
Be the first to comment on Michelle Lane's grant